Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Utilization of valproate: extent of inpatient use in the New York State Office of Mental Health.

Citrome L, Levine J, Allingham B.

Psychiatr Q. 1998 Winter;69(4):283-300.

PMID:
9793108
2.

Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998.

Citrome L, Levine J, Allingham B.

Psychiatr Serv. 2000 May;51(5):634-8.

PMID:
10783182
3.

Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders.

Tohen M, Castillo J, Pope HG Jr, Herbstein J.

J Clin Psychopharmacol. 1994 Feb;14(1):67-70.

PMID:
8151006
4.

Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.

Narendran R, Young CM, Valenti AM, Pristach CA, Pato MT, Grace JJ.

J Clin Psychiatry. 2001 Jul;62(7):509-16.

PMID:
11488360
5.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
6.

The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.

Chen H, Kennedy WK, Dorfman JH, Fincham JE, Reeves J, Martin BC.

Curr Med Res Opin. 2007 Jun;23(6):1351-65. Epub 2007 May 1.

PMID:
17559734
7.

Tolerability of divalproex sodium in elderly psychiatric patients with mixed diagnoses.

Puryear LJ, Kunik ME, Workman R Jr.

J Geriatr Psychiatry Neurol. 1995 Oct;8(4):234-7.

PMID:
8561838
8.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

9.

Incidence of delirium in older adults newly prescribed lithium or valproate: a population-based cohort study.

Shulman KI, Sykora K, Gill S, Mamdani M, Bronskill S, Wodchis WP, Anderson G, Rochon P.

J Clin Psychiatry. 2005 Apr;66(4):424-7.

PMID:
15816783
10.
11.

A naturalistic study of risperidone treatment outcome using prognosis-adjusted discharge rates in New York State inpatients.

Javitt DC, Cienfuegos A, Miniati M, Silipo G, Levine J, Allingham BH, Robinson J.

J Clin Psychiatry. 2002 Jul;63(7):585-90.

PMID:
12143914
12.
13.

Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine.

Yerevanian BI, Koek RJ, Mintz J.

J Affect Disord. 2007 Nov;103(1-3):5-11. Epub 2007 Jul 12.

PMID:
17628692
14.

The incidence and characteristics of clozapine- induced fever in a local psychiatric unit in Hong Kong.

Pui-yin Chung J, Shiu-yin Chong C, Chung KF, Lai-wah Dunn E, Wai-nang Tang O, Chan WF.

Can J Psychiatry. 2008 Dec;53(12):857-62.

PMID:
19087484
15.

Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients.

Hesslinger B, Normann C, Langosch JM, Klose P, Berger M, Walden J.

J Clin Psychopharmacol. 1999 Aug;19(4):310-5.

PMID:
10440457
16.

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.

Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME.

Arch Gen Psychiatry. 2005 Jan;62(1):37-45.

PMID:
15630071
17.

Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostility.

Citrome L, Shope CB, Nolan KA, Czobor P, Volavka J.

Int Clin Psychopharmacol. 2007 Nov;22(6):356-62.

PMID:
17917554
18.

Divalproex sodium augmentation of haloperidol in hospitalized patients with schizophrenia: clinical and economic implications.

Wassef AA, Hafiz NG, Hampton D, Molloy M.

J Clin Psychopharmacol. 2001 Feb;21(1):21-6.

PMID:
11199943
19.

Efficacy of divalproex therapy for schizoaffective disorder.

Bogan AM, Brown ES, Suppes T.

J Clin Psychopharmacol. 2000 Oct;20(5):520-2.

PMID:
11001235
Items per page

Supplemental Content

Write to the Help Desk